Indian mutual fund managers made significant changes to their portfolios in July, moving money between sectors as they looked for better growth opportunities and stronger fundamentals. IT, banking and pharmaceutical stocks were among the areas that saw considerable buying and selling activity, showing that fund managers are becoming more selective about where they deploy fresh capital.
According to recent portfolio data, mutual funds were net buyers of Indian shares worth around ₹15,900 crore in July, while foreign institutional investors sold stocks worth approximately ₹11,000 crore. This difference highlights the important role domestic mutual funds are playing in supporting the Indian equity market when foreign investors remain cautious.
The biggest changes were seen within the financial sector. Mutual funds reduced their exposure to several public-sector banks but increased investments in selected private-sector banks and non-banking financial companies. Fund managers appear to be favouring financial institutions where they see stronger earnings potential, better asset quality and long-term growth.
The shift does not mean mutual funds are moving away from banking altogether. Instead, the strategy appears to be more focused on choosing individual companies rather than taking a broad position across the entire banking sector. Some large private lenders and NBFCs attracted fresh buying, while exposure to certain PSU banks was reduced.
IT stocks also attracted renewed interest. Fund managers increased exposure to selected technology companies, including names such as HCL Technologies, Infosys and Tech Mahindra. The buying comes after a period when IT stocks faced pressure from concerns about global technology spending, weak demand in some overseas markets and uncertainty around artificial intelligence.
For mutual fund managers, the recent correction in some IT stocks has created an opportunity to increase exposure to companies that have strong balance sheets, established global clients and the ability to benefit from the growing use of artificial intelligence and digital services.
Pharmaceutical companies were another area where fund managers showed interest. Selected pharma stocks received fresh buying as investors looked for sectors that could offer relatively defensive earnings along with long-term growth. Companies such as Ajanta Pharma, Divi’s Laboratories and Torrent Pharmaceuticals were among the stocks that attracted mutual fund attention.
The portfolio changes also show that mutual funds are not simply following one broad market trend. They are actively moving money between companies and sectors depending on valuations, earnings expectations and future growth prospects. For example, even within IT and banking, some stocks were bought while others were sold.
Data from individual fund portfolios also shows the same pattern. Parag Parikh Flexi Cap Fund increased its holdings in HCL Technologies, Coal India and several other stocks during July. Other major flexi-cap funds also made changes to their portfolios, underlining the level of active management taking place across the industry.
The broader mutual fund industry remains strong despite the changes. Equity mutual fund inflows declined in July compared with June, falling about 14.8% month-on-month to ₹24,697 crore. Large-cap funds recorded their first monthly outflow since December 2023. At the same time, small-cap funds attracted record inflows of about ₹7,768 crore, while mid-cap funds received around ₹6,192 crore.
This suggests investors are still willing to put money into equities, but fund flows are becoming more selective. The strong interest in small- and mid-cap funds indicates that many investors continue to look for higher growth, while fund managers are simultaneously adjusting individual stock positions within their portfolios.
For the Indian stock market, continued domestic buying could provide some support if foreign investors become cautious again. However, market volatility, global economic conditions, company earnings and valuations will remain important factors.
Overall, the July portfolio reshuffle shows that mutual fund managers are actively repositioning their investments rather than making broad sector bets. IT, pharma and selected financial companies are attracting attention, while some PSU banks and other stocks are seeing reduced exposure. Investors will be watching the next round of portfolio disclosures to see whether these trends continue into August.
